{"Version": "1.0.0", "LINES": [{"text": "phase one two trial uh and roughly", "start": 15.179, "duration": 4.981, "ents": [{"label_": "CARDINAL", "text": "one"}, {"label_": "CARDINAL", "text": "two"}], "sentiment": -0.1}, {"text": "speaking phase one two trial the whole", "start": 18.359, "duration": 3.781, "ents": [{"label_": "CARDINAL", "text": "two"}], "sentiment": 0.2}, {"text": "trial is a phase one two but there's a", "start": 20.16, "duration": 4.619, "ents": [{"label_": "CARDINAL", "text": "two"}], "sentiment": 0.0}, {"text": "this trial but the first five patients", "start": 26.22, "duration": 4.44, "ents": [{"label_": "ORDINAL", "text": "first"}, {"label_": "CARDINAL", "text": "five"}], "sentiment": 0.25}, {"text": "treat one patient at a time uh and uh", "start": 32.399, "duration": 5.82, "ents": [{"label_": "CARDINAL", "text": "one"}], "sentiment": 0.0}, {"text": "had to do one uh one patient at a time", "start": 38.219, "duration": 4.561, "ents": [{"label_": "CARDINAL", "text": "one"}, {"label_": "CARDINAL", "text": "one"}], "sentiment": 0.0}, {"text": "board approved then the second patient", "start": 46.739, "duration": 4.14, "ents": [{"label_": "ORDINAL", "text": "second"}], "sentiment": 0.0}, {"text": "parallel so all 10 sites can can recruit", "start": 61.98, "duration": 7.44, "ents": [{"label_": "CARDINAL", "text": "10"}], "sentiment": 0.0}], "VIDEO_ID": "aPgkSfb8Yao", "VIDEO_DATA": [{"videoId": "aPgkSfb8Yao", "channelId": "UCxiA6FAQm7rPqb2Gl9pJ1-Q", "description": "SmallCap 60: Chitogenx (CHGX: CSE) (CHNXF: OTCQB) Completes Initial Portion of U.S Phase I/II #RotatorCuffRepair Clinical ...", "title": "#SmallCap 60: Chitogenx (CHGX: CSE) (CHNXF: OTCQB) Completes Initial Portion of U.S Phase I/II...", "publishedAt": "2022-12-28T21:54:21Z"}, {"videoId": "bsTb8rzKXSs", "channelId": "UCxiA6FAQm7rPqb2Gl9pJ1-Q", "description": "SmallCap 60: Reklaim (MYIDF: OTCQB) (MYID: TSXV) Says #Privacy Is Real, It's Not Going Away, $MYID Stands To Benefit ...", "title": "#SmallCap 60: Reklaim (MYIDF: OTCQB) (MYID: TSXV) Says #Privacy Is Real, It\u2019s Not Going Away...", "publishedAt": "2022-12-28T19:28:18Z"}, {"videoId": "Dsacuwgehvg", "channelId": "UCxiA6FAQm7rPqb2Gl9pJ1-Q", "description": "SmallCap 60: Leading #Cannabis Retailer Quantum 1 Cannabis (QQ: CSE) (QQQFF: OTC) Hit $6.9M In Revenue Quizam Media ...", "title": "#SmallCap 60: Leading #Cannabis Retailer Quantum 1 Cannabis  (QQ: CSE) (QQQFF: OTC) Hit $6.9M...", "publishedAt": "2022-12-28T19:19:47Z"}, {"videoId": "xLrL8Namg3c", "channelId": "UCxiA6FAQm7rPqb2Gl9pJ1-Q", "description": "SmallCap 60: Chitogenx (CHGX: CSE) (CHNXF: OTCQB) MOU Is About Investigating The #Tissue Healing Concept ChitogenX is ...", "title": "#SmallCap 60: Chitogenx (CHGX: CSE) (CHNXF: OTCQB) MOU Is About Investigating The #Tissue ...", "publishedAt": "2022-12-28T17:03:37Z"}, {"videoId": "o9jolCD9nF8", "channelId": "UCxiA6FAQm7rPqb2Gl9pJ1-Q", "description": "Through Reklaim, you can access your data, see how many companies are buying and selling your data, and how much your ...", "title": "#SmallCap 60: Reklaim (MYIDF: OTCQB) (MYID: TSXV) Talks Robust Organic and M&amp;A Growth", "publishedAt": "2022-12-28T16:54:15Z"}, {"videoId": "76dHy23dfNQ", "channelId": "UCxiA6FAQm7rPqb2Gl9pJ1-Q", "description": "SmallCap 60: Infinity Stone Ventures Corp. (GEMS: CSE) (GEMSF: OTC) Hits Massive #Graphite On #Rockstone Step-out Hole ...", "title": "#SmallCap 60: Infinity Stone Ventures Corp. (GEMS: CSE) (GEMSF: OTC) Hits Massive #Graphite...", "publishedAt": "2022-12-28T16:42:25Z"}]}